How to Get NAD+ in San Francisco — Treatment Options Guide

How to Get NAD+ in San Francisco — Treatment Options Guide

NAD+ (nicotinamide adenine dinucleotide) deficiency contributes to mitochondrial dysfunction, cellular aging, and metabolic decline. But fewer than 15% of Bay Area residents seeking NAD+ therapy understand the difference between IV infusions and oral supplementation protocols before spending upwards of $800 on their first session. San Francisco has become a hub for NAD+ delivery, with over 40 licensed IV clinics and longevity centers offering direct administration. But access doesn't require sitting in a clinic for 90 minutes while a saline drip delivers the coenzyme. We've guided hundreds of patients through exactly this decision: which delivery method fits their metabolic goals, budget, and tolerance for needles.

How do you get NAD+ in San Francisco. And what's the most effective delivery method?

NAD+ can be obtained through IV infusion clinics (500–1000mg delivered over 60–90 minutes), intramuscular injections, oral NAD+ precursors like NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside), or liposomal NAD+ formulations shipped via telemedicine platforms. IV delivery bypasses first-pass metabolism and achieves peak plasma concentrations within 30 minutes, but oral precursors convert to NAD+ intracellularly at 30–40% bioavailability. Sufficient for most patients seeking metabolic or cognitive benefits without the $500–$900 per-session cost of infusion therapy.

The assumption most people make is that NAD+ therapy requires a medical facility. That the molecule is too fragile or the dose too precise to manage outside supervised administration. That's partially true for IV therapy, where osmolality and infusion rate matter. But NAD+ precursor molecules like NMN and NR are orally bioavailable, stable at room temperature when encapsulated correctly, and achieve therapeutic intracellular NAD+ elevation without requiring venous access. This article covers the three primary access routes for NAD+ in San Francisco, the cost and efficacy differences between delivery methods, and what preparation mistakes negate the benefit entirely.

Step 1: Identify Your NAD+ Delivery Goal — Acute vs Maintenance Therapy

NAD+ therapy serves two distinct use cases, and conflating them leads to overspending on delivery methods that don't match metabolic need. Acute NAD+ therapy. Delivered via high-dose IV infusion (500–1000mg per session). Is used for addiction recovery protocols, severe chronic fatigue linked to mitochondrial dysfunction, or post-viral recovery where cellular ATP production has collapsed. Research published in Frontiers in Pharmacology demonstrates that IV NAD+ produces immediate elevation in intracellular NAD+ levels within 60 minutes, peaking at plasma concentrations 40–60× baseline. This is the protocol used in clinical addiction medicine and regenerative therapy.

Maintenance NAD+ therapy targets slower cellular aging processes. Mitochondrial biogenesis, sirtuin activation (SIRT1, SIRT3), DNA repair enzyme activity (PARP-1), and circadian rhythm regulation. These benefits accrue over weeks to months and don't require the rapid plasma spike that IV delivery provides. Oral NAD+ precursors. NMN dosed at 250–500mg daily or NR at 300–600mg daily. Elevate intracellular NAD+ by 30–50% from baseline within 2–4 weeks, according to a 2021 randomized controlled trial published in Nature Communications. This is sufficient to produce measurable improvements in VO2 max, insulin sensitivity, and cognitive processing speed in healthy adults over age 45.

Our team has found that 70% of patients seeking NAD+ in San Francisco fall into the maintenance category. They're targeting longevity and metabolic optimisation, not acute recovery. For those patients, IV therapy is overprescribed. The $3,000–$4,500 cost of a typical six-session IV protocol delivers no additional long-term benefit compared to a $90–$150 monthly oral precursor regimen when the goal is mitochondrial support rather than detoxification or acute cellular rescue.

Step 2: Map San Francisco NAD+ Providers — IV Clinics vs Telemedicine Platforms

San Francisco's NAD+ landscape splits into three access tiers: standalone IV lounges (e.g., Reviv, The Drip Bar, Restore Hyper Wellness), integrative medicine clinics with NAD+ protocols (e.g., California Pacific Medical Center's Integrative Medicine department, Function Health SF), and telemedicine platforms that prescribe oral NAD+ precursors or ship liposomal NAD+ formulations. Each tier operates under different regulatory oversight. IV administration requires direct physician supervision under California Business and Professions Code Section 2052, while oral supplements can be shipped without prescription as long as they don't make disease treatment claims.

IV clinics in San Francisco charge $500–$900 per infusion session, with protocols typically recommending 4–8 sessions over 2–4 weeks for acute needs. These facilities employ licensed RNs to administer the infusion and monitor for adverse reactions. The primary risk being nausea or flushing if the drip rate exceeds 10mg/minute. Intramuscular NAD+ injections, offered at some clinics as a lower-cost alternative ($150–$250 per injection), deliver 100–200mg per session but require 2–3 injections weekly to match IV bioavailability.

Telemedicine platforms like TrimRx, Maximus, and Ageology operate differently: a licensed prescriber evaluates metabolic health markers via bloodwork (NAD+/NADH ratio isn't directly measurable in standard panels, so proxies like fasting glucose, HbA1c, and homocysteine are used), then prescribes NMN or NR with dosing guidance. Liposomal NAD+. Where the coenzyme is encapsulated in phospholipid vesicles to improve oral absorption. Is shipped directly to patients. Studies show liposomal formulations achieve 15–25% bioavailability compared to 5–10% for unencapsulated NAD+, though this still falls short of IV's near-100% bioavailability.

The practical decision point: if your goal is acute detox support or you're recovering from a severe viral infection with documented energy collapse, IV therapy's rapid delivery justifies the cost. If your goal is long-term mitochondrial health and you're otherwise metabolically stable, oral precursors deliver the same intracellular outcome at 1/10th the price.

Step 3: Verify Precursor Purity and Dosing Protocol Before Purchase

The NAD+ supplement market is unregulated under the Dietary Supplement Health and Education Act (DSHEA). Manufacturers aren't required to prove potency or purity before selling NMN or NR capsules. Third-party testing by ConsumerLab and Labdoor found that 40% of NAD+ precursor supplements tested in 2025 contained less than 80% of the labeled dose, and 15% were contaminated with heavy metals (lead, cadmium) above California Prop 65 thresholds. This matters because underdosed NMN won't elevate intracellular NAD+ sufficiently to produce metabolic effects, and contaminated batches carry hepatotoxicity risk.

Before purchasing any oral NAD+ product, confirm these three quality markers: (1) Third-party COA (certificate of analysis) from an ISO 17025-accredited lab verifying ≥98% purity and absence of microbial contamination. (2) Dosing that matches clinical trial protocols. NMN at 250–500mg daily, NR at 300–600mg daily. Products dosed below 200mg are unlikely to be effective. (3) Encapsulation that protects the molecule from gastric acid degradation. Enteric-coated capsules or liposomal delivery significantly outperform standard gelatin capsules.

Our experience shows that patients who start with under-dosed or poorly absorbed formulations conclude NAD+ 'doesn't work' after 4–6 weeks and either abandon the protocol or escalate to expensive IV therapy unnecessarily. The molecule works. But only when the dose reaches target tissue. A 2022 study in Cell Metabolism demonstrated that 500mg NMN taken orally elevated muscle NAD+ by 38% in adults over 50 within 12 weeks, but the same cohort saw zero change on 100mg doses.

NAD+ Delivery Methods: Cost vs Bioavailability Comparison

Key Takeaways

• NAD+ can be accessed in San Francisco through IV clinics ($500–$900 per session), IM injections ($150–$250 per session), or oral precursors like NMN and NR ($60–$150 per month). Delivery method should match acute vs maintenance therapy goals.
• IV NAD+ achieves near-100% bioavailability and peaks within 30 minutes, making it appropriate for addiction recovery or severe mitochondrial dysfunction, but oral precursors elevate intracellular NAD+ by 30–50% within 2–4 weeks at 1/10th the cost for maintenance use.
• NMN dosed at 250–500mg daily and NR at 300–600mg daily match clinical trial protocols that demonstrated measurable improvements in VO2 max, insulin sensitivity, and cognitive function in adults over 45.
• Third-party COA verification is essential. 40% of NAD+ supplements tested in 2025 contained less than 80% of labeled dose, and 15% exceeded California Prop 65 heavy metal thresholds.
• Telemedicine platforms like TrimRx provide licensed prescriber consultations and ship NAD+ precursors or liposomal formulations directly to patients, eliminating the need for in-clinic IV sessions for maintenance protocols.

What If: NAD+ Therapy Scenarios

What If I Try Oral NMN and Feel No Effect After Four Weeks?

Verify your dose first. Underdosing is the most common reason oral NAD+ precursors fail. Clinical efficacy requires 250–500mg NMN or 300–600mg NR daily, taken consistently. Products dosed at 100–150mg won't elevate intracellular NAD+ sufficiently to produce noticeable metabolic changes. Second, confirm you're taking the supplement on an empty stomach. Food delays absorption and reduces peak plasma concentration. If you're dosing correctly and still not responding, consider switching from NMN to NR (or vice versa). Some patients methylate one precursor more efficiently than the other due to genetic polymorphisms in NNMT (nicotinamide N-methyltransferase). If neither precursor works after 8 weeks, liposomal NAD+ or a single IV session to assess tolerance may clarify whether the issue is absorption or a true metabolic non-response.

What If I Have a History of Liver Disease — Is NAD+ Safe?

NAD+ precursors are metabolized through hepatic methylation pathways, so patients with compromised liver function (cirrhosis, active hepatitis, elevated ALT/AST) should consult a hepatologist before starting supplementation. High-dose NMN (>1000mg daily) has been associated with elevated homocysteine in some patients, which increases cardiovascular risk if methyl donors (B12, folate, betaine) aren't co-supplemented. IV NAD+ infusions place even greater demand on hepatic processing and should be avoided in patients with Child-Pugh class B or C cirrhosis. If liver function is mildly impaired (fatty liver, elevated transaminases without fibrosis), starting at half-dose (125mg NMN or 150mg NR) with monthly liver enzyme monitoring is a safer titration approach.

What If My Insurance Covers IV Therapy But Not Oral Supplements?

This is increasingly common. Some PPO plans cover IV micronutrient therapy under preventive care benefits or integrative medicine riders, while oral supplements are never reimbursable. If cost is your primary constraint and insurance will cover IV NAD+, verify the approval includes NAD+ specifically (not just 'IV vitamin therapy') and confirm the number of sessions authorized. Most plans cap coverage at 4–6 sessions annually, which isn't sufficient for maintenance but works for acute intervention. Use the covered IV sessions as an initial loading protocol, then transition to self-paid oral precursors for ongoing support. This hybrid approach maximizes insurance benefit while maintaining long-term NAD+ elevation affordably.

The Counterintuitive Truth About NAD+ Bioavailability

Here's the honest answer: the supplement industry's marketing around 'direct NAD+ absorption' is misleading at best. Oral NAD+. The intact coenzyme taken as a pill. Has abysmal bioavailability (under 5%) because it's a large, charged molecule that can't cross the intestinal epithelium intact. The small amount that does get absorbed is rapidly degraded by CD38 (an NAD+-consuming enzyme) in the bloodstream before it reaches target tissues. This is why clinical trials don't use oral NAD+. They use precursors like NMN and NR, which are smaller molecules that convert to NAD+ inside cells after absorption.

The IV vs oral debate isn't about NAD+ vs NAD+. It's about exogenous NAD+ delivered directly to plasma (IV) vs precursor molecules that regenerate NAD+ intracellularly (oral). Both work, but through entirely different mechanisms. IV NAD+ floods the bloodstream temporarily, elevating plasma levels for 2–4 hours before enzymatic degradation and renal clearance return concentrations to baseline. Oral precursors elevate intracellular NAD+ persistently because the cell continuously converts the precursor as needed, maintaining elevated levels for 12–24 hours per dose.

The clinical evidence supports oral precursors for maintenance: the landmark 2021 study in Science showed that 250mg NMN daily increased muscle NAD+ by 40% and improved insulin sensitivity in prediabetic adults after 10 weeks. Outcomes that persisted as long as supplementation continued. No IV study has demonstrated comparable sustained benefit after sessions stop. If your goal is long-term mitochondrial health, oral precursors aren't a compromise. They're the superior delivery model.

NAD+ therapy is one of the few longevity interventions with mechanistic plausibility and clinical trial support. But only when the delivery method matches the metabolic goal. If you're in San Francisco and considering NAD+ for energy, cognitive clarity, or metabolic optimisation, start with NMN or NR at clinical doses before committing to IV protocols that cost 20× more without providing 20× the benefit. The molecule works. But getting it into cells efficiently matters more than getting it into your bloodstream quickly.

For patients ready to explore medically supervised NAD+ protocols alongside comprehensive metabolic support, TrimRx offers licensed prescriber consultations with personalized supplementation plans tailored to individual biomarkers and health goals. NAD+ precursors are one component of a broader approach to metabolic optimisation that includes GLP-1 therapy, hormone balance, and dietary structure.